Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $7.3450 (8.01%) ($7.3450 - $7.3450) on Thu. Jun. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.8% (three month average) | RSI | 74 | Latest Price | $7.3450(8.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 5.9% a day on average for past five trading days. | Weekly Trend | ATRA advances 9.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(37%) ARKK(35%) IBB(35%) ARKG(33%) XLC(33%) | Factors Impacting ATRA price | ATRA will decline at least -2.9% in a week (0% probabilities). VIXM(-63%) VXX(-39%) UNG(-25%) USO(-22%) XOP(-12%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.9% (StdDev 5.8%) | Hourly BBV | 2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $6.31(16.4%) | 10 Day Moving Average | $5.86(25.34%) | 20 Day Moving Average | $5.53(32.82%) | To recent high | -25.2% | To recent low | 56.6% | Market Cap | $546m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |